Prescription medicine
Albendazole Brand names: Albenza
Albendazole (Albenza) is a prescription medicine with an FDA approval on record since 1996. FDA's NDC Directory lists it from 8 generic labelers, and pharmacies paid $4.15 per albendazole 200 mg tablet in the October 7, 2026 NADAC survey.
- Generic listed
Check it at the source: the albendazole FDA label on DailyMed (effective September 30, 2019, Amneal Pharmaceuticals of New York LLC); the NDA 20666 record on Drugs@FDA; every albendazole label on DailyMed.
Highlights of the record
FDA label of September 30, 2019; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026; NADAC October 7, 2026
Used for
From the label: indications and usageAlbendazole is an anthelmintic drug indicated for: Treatment of parenchymal neurocysticercosis due to active lesions caused by larval forms of the pork tapeworm, Taenia solium.
Forms and strengths
- 200 mg
Film-coated tablet; tablet.
On the market
- Earliest approval on file
- June 11, 1996 Albenza, Impax Labs Inc; Drugs@FDA’s file, where older or withdrawn approvals can be missing
- Generic approvals
- 9 first September 21, 2018; 6 with a marketed status in Drugs@FDA
- Labelers listed (NDC)
- 10 of which 8 under generic applications, 2 under brand applications, repackagers included
Supply and safety
- Pharmacy cost (NADAC)
- $4.15 per tablet Albendazole 200 mg tablet
- Shortage (FDA)
- No current entry
- Recalls by its makers (FDA)
- No recall recorded
- FAERS reports
- 1,886 through July 30, 2026
What is albendazole used for?
From the label: indications and usageAlbendazole is an anthelmintic drug indicated for: Treatment of parenchymal neurocysticercosis due to active lesions caused by larval forms of the pork tapeworm, Taenia solium. ( 1.1 ) Treatment of cystic hydatid disease of the liver, lung, and peritoneum, caused by the larval form of the dog tapeworm, Echinococcus granulosus. […]
FDA pharmacologic class: Anthelmintic.
Source: FDA drug label (Albendazole), NDA020666 (Impax Labs Inc), as published by Amneal Pharmaceuticals of New York LLC, effective September 30, 2019 (SPL set 06b5eefc-0b95-4862-b9b6-770063f2adf0), via openFDA; the full label on DailyMed
Is there a generic for albendazole (Albenza)?
The FDA approved the first generic albendazole on September 21, 2018. 9 generic applications are approved; 6 of them carry a current (not discontinued) marketing status in Drugs@FDA; that status is not evidence that the generic is on sale.
FDA's NDC Directory lists albendazole from 8 labelers under a generic (ANDA) application and from 2 brand labelers. A listing means the company has registered the product for sale; it does not show that every pharmacy stocks it.
- 1996 earliest approval on file
- 2018 first generic approved
Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)
What do pharmacies pay for albendazole (Albenza)?
In CMS's NADAC survey of October 7, 2026, pharmacies paid $4.15 per Albendazole 200 mg tablet, down 31% from $6.02 on October 8, 2025. The survey records the price, not the reason for a change; large moves often follow a new generic or a list-price change. The chart's scale runs from the lowest to the highest price shown, not from zero. NADAC is what retail pharmacies paid their wholesalers, per unit, in CMS's monthly survey; what a patient pays depends on insurance and the pharmacy.
- Albendazole 200 mg tablet (generic)
| Strength and form | Brand or generic | Pharmacy cost | 30 tablets, or one pen or vial | 12-month change |
|---|---|---|---|---|
| Albendazole 200 mg tablet | Generic | $4.15 per tablet | $124.37 | -31% |
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price
What does the albendazole label say about other medicines?
The albendazole label names 5 other medicines in its interaction, contraindication or warning sections. The labels of 3 other medicines name albendazole. The sentences are the labels' own; a label lists what its studies and reports found, not every interaction.
| Medicine named | Section | What the label says |
|---|---|---|
| Aminophylline | drug interactions | Following a single dose of albendazole (400 mg), the pharmacokinetics of theophylline (aminophylline 5.8 mg/kg infused over 20 minutes) were unchanged. |
| Cimetidine | drug interactions | Albendazole sulfoxide concentrations in bile and cystic fluid were increased (about 2-fold) in hydatid cyst patients treated with cimetidine (10 mg/kg/day) (n = 7) compared with albendazole (20 mg/kg/day) alone (n = 12). |
| Dexamethasone | drug interactions | DRUG INTERACTIONS Dexamethasone: Steady-state trough concentrations of albendazole sulfoxide were about 56% higher when dexamethasone was coadministered with each dose of albendazole. |
| Praziquantel | drug interactions | In the fed state, praziquantel (40 mg/kg) increased mean maximum plasma concentration and area under the curve of albendazole sulfoxide by about 50% in healthy subjects (n = 10) compared with a separate group of subjects (n = 6) given albendazole alone. |
| Theophylline | drug interactions | Albendazole induces cytochrome P450 1A in human hepatoma cells; therefore, it is recommended that plasma concentrations of theophylline be monitored during and after treatment. |
Other labels that name albendazole
Source: FDA drug label (Albendazole), NDA020666 (Impax Labs Inc), as published by Amneal Pharmaceuticals of New York LLC, effective September 30, 2019 (SPL set 06b5eefc-0b95-4862-b9b6-770063f2adf0), via openFDA; the full label on DailyMed
What do FAERS reports show for albendazole?
The FDA Adverse Event Reporting System holds 1,886 reports that list albendazole among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 310 are coded as a death and 690 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.
Reports received each year
The most reported reactions
Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026
What next?
- Other anthelmintics
- the pharmacologic class, with prices and generics
- Albendazole side effects
- the label's list beside FAERS reports
- Check an interaction
- what two or more labels say about each other